Showing results (151-160 of 159) with videos related to
Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Oncogenesis|September 6, 2019
EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesotheliomaYi-Hung Carol Tan, Saumya Srivastava, Brian M Won, et al.Plos One|February 4, 2010
CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinasesYi-Hung Carol Tan, Soundararajan Krishnaswamy, Suvobroto Nandi, et al.Plos One|July 12, 2013
The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic targetBenjamin D Ferguson, Ren Liu, Cleo E Rolle, et al.Oncotarget|March 3, 2016
Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigationJanani Vigneswaran, Yi-Hung Carol Tan, Septimiu D Murgu, et al.Eclinicalmedicine|August 25, 2021
Maintaining safe lung cancer surgery during the COVID-19 pandemic in a global cityStephanie Fraser, Ralitsa Baranowski, Davide Patrini, et al.Lancet (London, England)|September 29, 2009
Challenges in evaluating surgical innovationPatrick L Ergina, Jonathan A Cook, Jane M Blazeby, et al.Lancet (London, England)|September 29, 2009
Evaluation and stages of surgical innovationsJeffrey S Barkun, Jeffrey K Aronson, Liane S Feldman, et al.Lancet (London, England)|September 29, 2009
No surgical innovation without evaluation: the IDEAL recommendationsPeter McCulloch, Douglas G Altman, W Bruce Campbell, et al.Cell Reports|July 28, 2021
A pan-cancer organoid platform for precision medicineBrian M Larsen, Madhavi Kannan, Lee F Langer, et al.Pageof 16